Table 2 Knowledge of health care providers (HPs) about the routes and doses of the; first, second and third line treatments

HP recognized Artesunate-sulphadoxine/pyrimethamine (ASP) as the first-line treatment

67

43

110

87.6-97.2

0.332

0.847

93.1

91.5

92.4

HP stated the recommended dose for ASP in mg correctly

22

13

35

21.9-38

1.787

0.618

32.8

29.5

29.7

HP recognized how ASP is taken correctly

44

24

68

49.0-66.8

1.172

0.279

61.1

51.1

57.1

HP recognized Artemether + lumefantrine (AL) as the second-line treatment

48

24

72

51.7-69.3

7.084

0.069

66.7

51.1

60.5

HP stated the recommended dose for AL in mg correctly

26

16

42

26.7-43.9

1.800

0.407

36.1

34

35.3

HP recognized how AL is taken correctly.

46

24

70

50.0-67.6

1.932

0.381

63.9

51.1

58.8

HP recognized quinine as the third-line treatment

60

42

102

79.4-92.2

4.201

0.122

83.3

89.4

85.7

HP stated the recommended dose for oral quinine correctly

56

18

74

53.5-71.0

20.732

0.000

77.8

38.3

62.2

HP recognized the main indication for administering injectable quinine in malaria patients

43

32

75

54.3-71.1

1.358

0.715

59.7

68.1

63

ACT knowledgable*

16

10

26

14.6-29.4

0.026

1

22.5

21.3

22